DECHECCHI, MARIACRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.503
EU - Europa 2.664
AS - Asia 1.924
SA - Sud America 260
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 6
Totale 8.439
Nazione #
US - Stati Uniti d'America 3.376
RU - Federazione Russa 1.028
SG - Singapore 700
CN - Cina 641
GB - Regno Unito 544
BR - Brasile 193
IT - Italia 192
HK - Hong Kong 172
SE - Svezia 170
FR - Francia 157
VN - Vietnam 141
FI - Finlandia 137
IE - Irlanda 137
DE - Germania 135
KR - Corea 80
CA - Canada 62
BD - Bangladesh 37
IN - India 29
UA - Ucraina 28
NL - Olanda 27
EC - Ecuador 22
MX - Messico 20
IQ - Iraq 19
AT - Austria 18
BE - Belgio 17
JP - Giappone 17
PL - Polonia 16
TR - Turchia 16
ID - Indonesia 15
AR - Argentina 13
NG - Nigeria 10
MA - Marocco 8
PK - Pakistan 8
ZA - Sudafrica 8
KZ - Kazakistan 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
CL - Cile 6
CO - Colombia 6
CZ - Repubblica Ceca 6
ES - Italia 6
JM - Giamaica 6
AU - Australia 5
LV - Lettonia 5
NO - Norvegia 5
PE - Perù 5
PR - Porto Rico 5
PY - Paraguay 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
AL - Albania 4
AZ - Azerbaigian 4
CH - Svizzera 4
CR - Costa Rica 4
GT - Guatemala 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
IR - Iran 4
NP - Nepal 4
RO - Romania 4
TN - Tunisia 4
AM - Armenia 3
CW - ???statistics.table.value.countryCode.CW??? 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GR - Grecia 3
NI - Nicaragua 3
PH - Filippine 3
PT - Portogallo 3
SN - Senegal 3
TG - Togo 3
UZ - Uzbekistan 3
VE - Venezuela 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
HR - Croazia 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
MY - Malesia 2
PA - Panama 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BJ - Benin 1
BS - Bahamas 1
BT - Bhutan 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
CY - Cipro 1
EG - Egitto 1
EU - Europa 1
GH - Ghana 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LB - Libano 1
MK - Macedonia 1
Totale 8.402
Città #
Ashburn 430
Southend 429
Singapore 377
Moscow 356
San Jose 317
Chandler 305
Dallas 245
Woodbridge 212
Jacksonville 191
Hong Kong 171
Ann Arbor 140
Dublin 136
Beijing 135
Houston 130
Council Bluffs 126
New York 116
The Dalles 112
Verona 67
Los Angeles 65
Ho Chi Minh City 50
Jinan 48
Lawrence 47
Princeton 47
Wilmington 43
Helsinki 40
Munich 36
Santa Clara 35
Nanjing 34
Hanoi 32
Shenyang 32
Buffalo 30
Seoul 28
Sindelfingen 23
Columbus 22
São Paulo 21
Tianjin 21
Orem 18
Vienna 18
Brussels 17
Montreal 16
Ningbo 16
Tokyo 16
Turku 16
Hebei 14
Kent 14
Lancaster 14
Milan 14
Nanchang 14
Redondo Beach 14
Boardman 13
Changsha 13
Chennai 13
Denver 13
Guangzhou 13
Haikou 13
Hangzhou 13
Taizhou 13
Warsaw 13
Mexico City 12
Rome 12
Chicago 11
Frankfurt am Main 11
Zhengzhou 11
Baghdad 10
Jiaxing 10
London 10
San Francisco 10
Toronto 10
Amsterdam 9
Barnet 9
Newark 9
Seattle 9
Stockholm 9
Boston 8
Redwood City 8
Taiyuan 8
Abuja 7
Charlotte 7
Dearborn 7
Guayaquil 7
Haiphong 7
Brooklyn 6
Da Nang 6
Dhaka 6
Jakarta 6
Lanzhou 6
Leiden 6
Manchester 6
Paris 6
Vancouver 6
Washington 6
Atlanta 5
Auburn Hills 5
Belo Horizonte 5
Biên Hòa 5
Curitiba 5
Istanbul 5
La Paz 5
Naples 5
Norwalk 5
Totale 5.283
Nome #
Effetto anti-infiammatorio del miglustat su cellule dell'epitelio bronchiale 281
EFFETTO ANTI-INFIAMMATORIO DI TRIMETIL-ANGELICINA SU CELLULE DELL'EPITELIO BRONCHIALE 256
ANTI-INFLAMMATORY EFFECT OF MIGLUSTAT: SPHINGOLIPID METABOLISM AS A THERAPEUTIC TARGET FOR CF LUNG INFLAMMATION 238
PSEUDOMONAS AERUGINOSA MODULATES THE PHOSPHORYLATION CHANGES OF SCAFFOLDING PROTEINS AND APICAL EXPRESSION OF CFTR IN AIRWAYS 221
Pharmacological modulators of sphingolipid metabolism for the treatment of cystic fibrosis lung inflammation 219
Effect of beta-Sitosterol in pro-inflammatory gene expression in bronchial epithelial cells 212
Effects of decoy molecules targeting NFkappaB transcription factors in Cystic fibrosis IB3-1 cells: Recruitment of NFkappaB to the IL-8 gene promoter and transcription of the IL-8 gene 210
Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study 208
DOWN-MODULATION OF NEUTROPHIL CHEMOTACTIC SIGNALLING BY TARGETING THE METABOLISM OF SPHINGOLIPIDS 204
Modulators of Sphingolipid Metabolism Reduce Lung Inflammation 199
ANTI-INFLAMMATORY MOLECULES OBTAINED FROM VIRTUAL SCREENING OF A FUROCOUMARIN DATABASE AGAINST NF-KB 199
Chemical conjugation of ΔF508-CFTR corrector deoxyspergualin to transporter human serum albumin enhances its ability to rescue Cl- channel functions. 197
Docking of molecules identified in bioactive medicinal plants extracts into the p50 NF-kappaB transcription factor: correlation with inhibition of NF-kappaB/DNA interactions and inhibitory effects on IL-8 gene expression 184
Geni modificatori del fenotipo polmonare in Fibrosi Cistica 184
Anti-inflammatory effect of miglustat in bronchial epithelial cells 184
Chloride conductance in membrane vesicles from human placenta using a fluorescent probe. Implications for cystic fibrosis 183
COMBINED EFFECTS OF FUROCOUMARIN COMPOUNDS AS ANTI-INFLAMMATORY AND CFTR POTENTIATOR IN CALU-3 EPITHELIAL CELLS 183
Pyrogallol, an active compound from the medicinal plant Emblica officinalis, regulates expression of pro-inflammatory genes in bronchial epithelial cells 182
Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis 181
IMINOSUGAR-BASED INHIBITORS OF CERAMIDE GLUCOSYL-TRANSFERASE (GLCCERT) AND NONLYSOSOMAL GLUCOSYLCERAMIDASE (GBA2) REDUCE THE INFLAMMATORY RESPONSE TO P. AERUGINOSA IN CF BRONCHIAL EPITHELIAL CELLS 179
Expression of microRNA-93 and Interleukin-8 during Pseudomonas aeruginosa-mediated induction of proinflammatory responses 177
Modulation of expression of genes involved in leukocyte chemotaxis by interfering with nuclear transcription factors 174
Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa. 170
BETA-SITOSTEROL, IDENTIFIED FROM NIGELLA ARVENSIS, INHIBITS THE INDUCTION OF IL-8 GENE IN BRONCHIAL EPITHELIAL CELLS 167
GBA2-Encoded β-Glucosidase Activity Is Involved in the Inflammatory Response to Pseudomonas aeruginosa 166
Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5 163
Transient Receptor Potential Ankyrin 1 Channels Modulate Inflammatory Response in Respiratory Cells from Patients with Cystic Fibrosis. 161
Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening 159
A peptide-nucleic acid targeting miR-335-5p enhances expression of cystic fibrosis transmembrane conductance regulator (CFTR) gene with the possible involvement of the CFTR scaffolding protein NHERF1 158
Circulating microRNAs as emerging non-invasive biomarkers for gliomas 156
Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions 150
Protein kinase C activates chloride conductance in C127 cells stably expressing the cystic fibrosis gene 146
GM1 as adjuvant of innovative therapies for cystic fibrosis disease 146
miRNAs in serum exosomes for differential diagnosis of brain metastases 145
NIGELLA ARVENSIS EXTRACT INHIBITS THE INDUCTION OF IL-8 GENE IN BRONCHIAL EPITHELIAL CELLS 142
PLCB3 in pro-inflammatory signaling in bronchial epithelial cells 135
Oxidative stress and antioxidant therapy in cystic fibrosis 132
Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis 131
TRIMETHYLANGELICIN MODULATES NEUTROPHIL CHEMOTAXIS IN MURINE MODEL OF PSEUDOMONAS AERUGINOSA ACUTE LUNG INFECTION 129
Medicinal plant extracts inhibit the induction of pro-inflammatory genes in bronchial epithelial cells 129
Silencing of genes coding for transcription factors: biological effects of decoy oligonucleotides on cystic fibrosis bronchial epithelial cells 122
Unravelling the role of sphingolipids in cystic fibrosis lung disease 119
Miglustat and DGJ reduce the inflammatory response to pseudomonas aeruginosa, TNF-alpha and IL-1beta in bronchial epithelial cells 118
Assessing the Potential of N-Butyl-l-deoxynojirimycin (l-NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent 116
Targeting transcription factor activity as a strategy to inhibit pro-inflammatory genes involved in cystic fibrosis: decoy oligonucleotides and low-molecular weight compounds 114
β-sitosterol ameliorates inflammation and Pseudomonas aeruginosa lung infection in a mouse model 112
Sphingolipids and plasma membrane hydrolases in human primary bronchial cells during differentiation and their altered patterns in cystic fibrosis 110
INVOLVEMENT OF THE CAAT/ENHANCER BINDING PROTEIN HOMOLOGOUS TRANSCRIPTION FACTOR (CHOP) IN P-AERUGINOSA-DEPENDENT IL-8 TRANSCRIPTION 102
LACK OF EFFICACY OF DEXAMETHASONE IN REDUCING THE INFLAMMATORY RESPONSE TO P. AERUGINOSA IN A CELL LINE DERIVED FROM BRONCHIAL EPITHELIUM OF A CF PATIENT 102
Molecular basis of cystic fibrosis: from bench to bedside 98
New TMA (4,6,4'-Trimethyl angelicin) Analogues as Anti-Inflammatory Agents in the Treatment of Cystic Fibrosis Lung Disease 98
Treatment of human airway epithelial Calu-3 cells with a peptide-nucleic acid (PNA) targeting the microRNA miR-101-3p is associated with increased expression of the cystic fibrosis Transmembrane Conductance Regulator () gene 88
Totale 8.439
Categoria #
all - tutte 27.513
article - articoli 16.517
book - libri 0
conference - conferenze 9.135
curatela - curatele 0
other - altro 0
patent - brevetti 1.269
selected - selezionate 0
volume - volumi 592
Totale 55.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022212 0 0 0 0 17 14 6 23 20 13 31 88
2022/2023909 58 124 67 149 76 219 13 64 111 8 16 4
2023/2024506 24 36 29 60 49 117 7 31 0 34 101 18
2024/20251.018 50 57 34 192 30 39 73 43 157 56 96 191
2025/20263.370 222 166 249 511 845 247 330 155 295 195 68 87
2026/2027580 103 64 133 262 18 0 0 0 0 0 0 0
Totale 8.439